Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Subst Abus. 2012;33(1):48–59. doi: 10.1080/08897077.2011.609438

Table 3.

Treatment Completion and Six-Month Outcomes

Group Injection Status Completed 6 month follow-up Urine positive for Opioids at 6 months Any Incarcerations in past 6 months Employed at 6 month follow-up
All Sites
Completers (Received all monthly injections) 28/61 (46%) 27/28 (96%)*** 1/26 (4%)** 4/27 (15%)* 15/27 (56%)
Non-completers (Did not receive all monthly injections) 33/61 (54%) 13/33 (39%) 4/9 (44%) 9/18 (50%) 5/13 (39%)
Total 61 40/61 (66%) 5/35 (14%) 13/45 (29%) 20/40 (50%)
Penn Site
Completers (Received all monthly injections) 16/35 (46%) 16/16 (100%)** 0/16 (0%)* 1/16 (6%)* 12/16 (75%)*
Non-completers (Did not receive all monthly injections) 19/35 (54%) 9/19 (47%) 2/6 (33%) 5/10 (50%) 3/9 (33%)
Total 35 25/35 (71%) 2/22 (9%) 6/26 (23%) 15/25 (60%)

Total of 6 injections at Penn, Rhode Island, Columbia, Baltimore and 3 injections for NYU.

*

p < .05

**

p < .01

***

p < .001